By Alejandro Luna - Mon, 03/13/2023 - 09:00
The only people who could oppose the proper functioning of a linkage system are those who intend to violate patents, writes Alejandro Luna.
More Professional Services
By Alejandro Luna - Wed, 12/07/2022 - 10:00
Alejandro Luna looks at the impact of Compulsory Licenses and provides potential alternatives.
By Miriam Bello - Thu, 09/22/2022 - 10:13
Still a long way to go despite IP and life sciences regulatory improvement under federal industrial property law, says Alejandro Luna.
By Antonio Gozain - Thu, 09/01/2022 - 15:45
In addition to an evolving regulation, cybersecurity investment and education play an essential role in the correct use and protection of data.
By Alejandro Luna - Thu, 07/21/2022 - 10:00
What does Mexican law say regarding compensation for delays in issuing patent validity rulings? Alejandro Luna Fandiño looks at the issue.
By Miriam Bello - Fri, 06/11/2021 - 08:00
OLIVARES’s Alejandro Luna explains the legal implications of waiving COVID-19 vaccine patents, the new IP law and UNOPS purchase schemes.
By Miriam Bello - Thu, 06/10/2021 - 16:06
After many controversies, COVID-19 patent waivers seem to be off the table as a measure to enhance vaccine access. Find out why.
By Alejandro Luna - Wed, 01/27/2021 - 09:26
Obtaining an equitable and global distribution of the vaccine will not be an easy challenge and requires the cooperation of all the sectors involved.
By Miriam Bello - Fri, 11/20/2020 - 09:40
Foreign companies could face fewer barriers to introduce medicines to Mexico following President López Obrador’s most recent order.
By Miriam Bello - Tue, 10/27/2020 - 16:38
What will the new IP law bring to the pharmaceutical industry?